<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03371368</url>
  </required_header>
  <id_info>
    <org_study_id>AAAR3662</org_study_id>
    <nct_id>NCT03371368</nct_id>
  </id_info>
  <brief_title>Metabolism and Bariatric Surgery Study</brief_title>
  <official_title>Metabolic and Endocrine Effects of Bariatric Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if diet-induced weight loss causes different
      changes in hormones that control appetite and glucose control than surgery-induced weight
      loss. The overall research plan is a non-randomized prospective study of 3 different WL
      interventions and a lean and an obese healthy control group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Weight loss (WL) improves obesity-related co-morbidities such as type 2 diabetes mellitus
      (DM). Unfortunately, WL through life-style interventions has a high degree of recidivism and
      the paucity of safe, effective and affordable pharmacotherapy together with an increase in
      the prevalence of morbid obesity has led to a rise in bariatric procedures. Clinical trials
      in patients with DM show that improvements in glycemia vary between procedures and occur in
      the following order: Roux-en-Y gastric bypass (RYGB) &gt; sleeve gastrectomy (SG) &gt; laparoscopic
      adjustable gastric banding (LAGB) &gt; medical/life-style therapy. This order mirrors the amount
      of WL with each intervention and is a major driver of glycemic improvement. The investigators
      have shown profound changes unique to RYGB and SG in levels of hormones that make up the
      &quot;gut-brain&quot; and &quot;enteroinsular&quot; axes. The association of some of these hormones with insulin
      sensitivity (IS) and glycemia independent of WL strongly suggests that glycemic improvements
      after surgery occur in part through pathways that are distinct from just calorie restriction.
      This study builds on results showing that levels of fibroblast growth factor 19 (FGF19), a
      protein secreted by intestinal cells, are increased after RYGB and SG but not after low
      calorie diet (LCD). This difference may affect hormones that control the stress response to
      weight loss. The investigators will explore differences in hormones of the gut that affect
      appetite, body weight, and stress response in healthy lean and obese individuals. Obese
      individuals will also be studied before and after 15% body weight loss induced by LCD, RYGB
      or SG, and again at 1 year after study enrollment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 16, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Cohort</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in urine free cortisol level</measure>
    <time_frame>Baseline and 1 year</time_frame>
    <description>A linear mixed effects model will be used to compare the cortisol changes between the LCD and the surgery groups. Specifically, cortisol change will be modeled as longitudinal outcome, and the main predictors are time and treatment group, and the time-treatment interaction.</description>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Insulin Resistance</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Gastric Bypass Non-diabetic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Roux-en-Y gastric bypass surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sleeve Gastrectomy Non-diabetic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>sleeve gastrectomy surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Very Low Calorie Diet Non-diabetic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>very low calorie diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Obese Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Non-diabetic obese subjects</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lean Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Non-diabetic lean subjects</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Roux-en-Y Gastric Bypass</intervention_name>
    <description>NOTE: The surgery is NOT paid for by the study</description>
    <arm_group_label>Gastric Bypass Non-diabetic</arm_group_label>
    <other_name>RYGBP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sleeve Gastrectomy</intervention_name>
    <description>NOTE: The surgery is NOT paid for by the study</description>
    <arm_group_label>Sleeve Gastrectomy Non-diabetic</arm_group_label>
    <other_name>SG</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Very Low Calorie Diet</intervention_name>
    <description>Weight loss with calorie restricted liquid diet. Subjects will be placed on a 800 kcal/day diet with a meal replacement (Optifast) provided by the investigator for 12 weeks. Then, transitioning to a higher calorie diet intake up to a year. Subjects will be closely monitored by study dietitian</description>
    <arm_group_label>Very Low Calorie Diet Non-diabetic</arm_group_label>
    <other_name>VLCD</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Men and women Ages 18-65 Years Old

        Exclusion Criteria:

          1. Altered Sleep-wake Cycle

          2. Type 1 or 2 diabetes

          3. Previous Bariatric Surgery

          4. Lactose Intolerance

          5. Any Special Diet restrictions.

          6. Use of medications that may affect body weight at screening or during a 3 month period
             prior.

          7. Untreated thyroid disease

          8. Other medical conditions like Cushing's, acromegaly, Hearth failure, Crohn's disease,
             etc

          9. Pregnancy

         10. Tobacco or opioid use

         11. Alcohol dependence

         12. &gt; 3% weight change over the 3month period prior to screening

         13. Unwillingness to maintain current level of physical activity over duration of study
             period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Judith Korner, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Judith Korner, MD, PhD</last_name>
    <phone>(212) 305-3725</phone>
    <email>jk181@cumc.columbia.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gerardo Febres, MD</last_name>
    <phone>212-342-0281</phone>
    <email>gjf41@cumc.columbia.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judith Korner, M.D, PhD</last_name>
      <phone>212-305-3725</phone>
      <email>jk181@cumc.columbia.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2017</study_first_submitted>
  <study_first_submitted_qc>December 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2017</study_first_posted>
  <last_update_submitted>December 7, 2017</last_update_submitted>
  <last_update_submitted_qc>December 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Judith Korner</investigator_full_name>
    <investigator_title>Professor of Medicine at the Columbia University Medical Center</investigator_title>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Insulin Resistance</keyword>
  <keyword>Bariatric Surgery</keyword>
  <keyword>Gastric Bypass</keyword>
  <keyword>Sleeve Gastrectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

